CervoMed Inc. (CRVO)
USD 2.0
(3.09%)
USD 2.0
(3.09%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7.14 Million | - | - | - | - | - |
| Cost of Revenue | 8.43 Million | 1.33 Million | 93.41 Thousand | 103.16 Thousand | 97.91 Thousand | 110.37 Thousand |
| Gross Profit | -1.29 Million | -1.33 Million | -93.41 Thousand | -103.16 Thousand | -97.91 Thousand | -110.37 Thousand |
| Operating Expenses | 14.95 Million | 3.47 Million | 15.94 Million | 15.87 Million | 11.45 Million | 11.91 Million |
| Selling, General and Administrative Expenses | 6.51 Million | 2.13 Million | 7.44 Million | 6.44 Million | 4.83 Million | 6.16 Million |
| Research and Development Expenses | 8.43 Million | 1.33 Million | 8.49 Million | 9.42 Million | 6.61 Million | 5.75 Million |
| Other Expenses | - | -2.38 Million | - | - | - | - |
| Cost and Expenses | 14.95 Million | 3.47 Million | 16.03 Million | 15.97 Million | 11.55 Million | 12.02 Million |
| Operating Income | -7.81 Million | -3.47 Million | -16.03 Million | -15.97 Million | -11.55 Million | -12.02 Million |
| Interest Expense | - | 587.00 | - | - | - | - |
| Income Tax Expense | - | -3.47 Million | -443.89 Thousand | -1.67 Million | 332.88 Thousand | -437.28 Thousand |
| Earnings before Tax | -2.17 Million | -5.8 Million | -24.53 Million | -15.86 Million | -11.46 Million | -18.8 Million |
| Net Income | -2.17 Million | -5.8 Million | -24.09 Million | -14.18 Million | -11.79 Million | -18.36 Million |
| Earnings Per Share Basic | -0.82 | -11.20 | -18.51 | -19.76 | -131.95 | -424.93 |
| Earnings Per Share Diluted | -0.82 | -11.20 | -18.51 | -19.76 | -131.95 | -424.93 |
| Weighted Average Shares Outstanding | 2.66 Million | 518.13 Thousand | 1.3 Million | 717.75 Thousand | 89.42 Thousand | 43.23 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 2.66 Million | 518.13 Thousand | 1.3 Million | 717.75 Thousand | 89.42 Thousand | 43.23 Thousand |
| Gross Margin | -0.18 | - | - | - | - | - |
| EBIT Margin | -0.30 | - | - | - | - | - |
| Profit Margin | -0.30 | - | - | - | - | - |
| EBITDA | -2.17 Million | - | -24.44 Million | -15.75 Million | -11.36 Million | -18.69 Million |
| Earnings Before Tax Margin | -1.09 | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 3.28 Million | 2.34 Million | 2.49 Million | 7.14 Million | 1.52 Million | - |
| Cost of Revenue | - | 2.81 Million | 2.85 Million | 8.43 Million | 1.79 Million | - |
| Gross Profit | 3.28 Million | -467 Thousand | -364.77 Thousand | -1.29 Million | -265 Thousand | - |
| Operating Expenses | 6.28 Million | 4.94 Million | 4.97 Million | 14.95 Million | 4.2 Million | 2.29 Million |
| Selling, General and Administrative Expenses | 2.51 Million | 2.12 Million | 2.11 Million | - | 2.41 Million | 2.22 Million |
| Research and Development Expenses | 3.77 Million | 2.81 Million | 2.85 Million | - | 1.79 Million | 72.18 Thousand |
| Other Expenses | -247.00 | -30.00 | -600.00 | 5.42 Million | 4.77 Million | -212.21 Thousand |
| Cost and Expenses | 6.28 Million | 4.94 Million | 4.97 Million | 14.95 Million | 4.2 Million | 2.29 Million |
| Operating Income | -2.99 Million | -2.59 Million | -2.48 Million | -7.81 Million | -2.67 Million | -2.29 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 1.00 | 2.00 | 800 Thousand | 800 Thousand | -2.67 Million | - |
| Earnings before Tax | -2.31 Million | -2.51 Million | -2.36 Million | -2.17 Million | 2.15 Million | -2.11 Million |
| Net Income | -2.31 Million | -2.51 Million | -2.36 Million | -2.17 Million | 2.15 Million | -2.11 Million |
| Earnings Per Share Basic | -0.27 | -0.41 | -0.42 | - | 0.65 | -1.55 |
| Earnings Per Share Diluted | -0.27 | -0.41 | -0.42 | - | -0.70 | -1.55 |
| Weighted Average Shares Outstanding | 8.7 Million | 6.17 Million | 5.67 Million | 2.66 Million | 3.3 Million | 1.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.7 Million | 6.17 Million | 5.67 Million | 2.66 Million | 3.76 Million | 1.36 Million |
| Gross Margin | 1.00 | -0.20 | -0.15 | -0.18 | -0.17 | - |
| EBIT Margin | -0.91 | -1.11 | -1.00 | - | -1.75 | - |
| Profit Margin | -0.70 | -1.07 | -0.95 | -0.30 | 1.41 | - |
| EBITDA | -2.99 Million | -2.59 Million | -2.48 Million | - | -2.67 Million | -2.29 Million |
| Earnings Before Tax Margin | -0.91 | -1.11 | -1.00 | -1.09 | -1.75 | - |
CRGX
HXL
SESN
ALQWA
300102
PTOS